Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Ampronix

Novel Inflator Suitable for Multiple Interventional Balloon Systems

By HospiMedica International staff writers
Posted on 15 Jul 2013
Print article
Image: The basixTOUCH high-pressure balloon inflator (Photo courtesy of Merit Medical).
Image: The basixTOUCH high-pressure balloon inflator (Photo courtesy of Merit Medical).
A novel high-pressure syringe for use in catheterization laboratories could potentially replace multiple inflation systems by offering a wide range of available pressure.

The basixTOUCH high-pressure balloon inflator delivers pressure of up to 3546 kPa (or 35 atmospheres) for inflating an angioplasty balloon or other interventional device, continuously measuring the pressure within the balloon. Once the intervention has ended, the balloon can be quickly deflated, dropping the pressure rapidly thanks to a quick-release handle. The system can be prepped and primed single-handedly, and eliminates the need to use multiple inflation devices in some advanced interventional cases, thanks to its high-pressure range.

Two important features of the device include an ergonomic handle and threads that ensure high pressures can be reached rapidly, reaching maximum with less than three clockwise rotations of the handle. The system is supplied with a 30 mL syringe barrel that accommodates additional fluid for large balloons. The basixTOUCH high-pressure balloon inflator is a product of Merit Medical (South Jordan, UT, USA), and has been approved by the US Food and Drug Administration (FDA).

“We believe the introduction of the basixTOUCH clearly places Merit in the worldwide leadership position for inflation devices which are used in numerous interventional and peripheral procedures,” said Fred Lampropoulos, chairman and CEO of Merit Medical. “This device and its derivatives have the potential, when combined with other devices such as our hemostasis valves, to become the largest single revenue producing product in Merit’s history.”

Related Links:
Merit Medical



Print article
Fluke Biomedical
JD Honigberg International

Channels

Women's Health

view channel
Image: The vaginal probe device, designed for cervical cancer screening (Photo courtesy of Biop Medical).

Optical Scanner Advances Cervical Cancer Screening

A new technology optimizes the cervical cancer (CC) screening process into a single, three-minute painless optical scan. The Biop device is a probe inserted into the vaginal canal that optically identifies... Read more

Business

view channel

Otsuka and IBM Partner in Digital Health Venture

IBM (Armonk, NY, USA) and Otsuka Pharma (Tokyo, Japan) have formed a joint venture to market software that will integrate and analyze psychiatric patient data in Japan. The joint venture will be named Otsuka Digital Health, with the pharma company taking an 85% stake and IBM Japan holding the remaining 15%.... Read more
Copyright © 2000-2016 Globetech Media. All rights reserved.